Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

sergei_svarovsky

Axim Biotechnologies Inc announces Dr Sergei Svarovsky as Chief Scientific Officer of subsidiary Sapphire Biotech

May 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Axim Biotechnologies has announced that Dr Sergei Svarovsky will be the new Chief Scientific Officer of its subsidiary Sapphire Biotech. …
Appointment
fda

FDA approves Sanofi’s Dupixent for children with dermatitis

May 27, 2020 Research and Development Dupixent, Sanofi, atopic eczema

The FDA has approved Sanofi’s Dupixent (dupilumab) for children between ages 6 to 11 with moderate to severe atopic dermatitis. …
News
pharmafocus_june_2020_front_cover

The June 2020 issue of Pharmafocus is available to read free online now!

May 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, coronavirus, data management, pharma, rare disease, treatment access

The latest monthly edition of Pharmafocus, the June 2020 issue, is available to read for free online now! The world remains …
News
cdc_coronavirus

Pharmafile.com’s weekly COVID-19 news round-up

May 27, 2020 Research and Development COVID-19, coronavirus, coronavirus round up

COVID-19 vaccines and treatments continue to dominate the news, as AstraZeneca is attempting to deliver one billion doses of coronavirus …
News

NICE reverses previous stance to recommend Roche’s Tecentriq in extensive-stage small-cell lung cancer

May 27, 2020 Research and Development, Sales and Marketing NICE, Roche, lung cancer, tecentriq

NHS patients with treatment-naïve extensive-stage small-cell lung cancer (ES-SCLC) in England and Wales will soon have access to a new …
News
nhsssssss

Remdesivir available to select COVID-19 patients through the NHS

May 27, 2020 Research and Development coronavirus, covid19

Gilead Sciences Ebola drug remdesivir will be available for selected patients who are suffering from coronavirus through the NHS. The …
News
darren_taylor1

Living with multiple ‘invisible’ conditions

May 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, rare disease

Darren Taylor lives with a range of conditions including Dercum’s disease, cystic fibrosis, fibromyalgia with chronic fatigue, and Tietze syndrome, …
Feature
4223373030_df7722f9f7_c

Harvard study suggests monkeys develop immunity after receiving COVID-19 vaccines

May 21, 2020 Research and Development COVID-19, vaccine coronavirus

“The COVID-19 pandemic has made the development of a safe, effective, and deployable vaccine a critical global priority”, said researchers …
News
covid

Pharmafile.com’s weekly COVID-19 news round-up

May 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Trump, coronavirus

Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …
News
mit

MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic

May 20, 2020 Research and Development, Sales and Marketing COVID-19, MIT, coronavirus, regulatory

A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …
News
ai

New research outlines guidelines for the ethical use of AI in healthcare

May 20, 2020 Research and Development AI, coronavirus

A new study published in The Lancet has called on the global health community to establish guidelines to develop and …
News

Nanotechnology could be used to assess mortality risk in COVID-19 patients

May 20, 2020 Research and Development COVID-19, coronavirus, nanotechnology

Doctors could use nanotechnology to assess the morality risk from COVID-19, according to research from Michigan State University. Morteza Mahmoudi, …
News
diabetes_3

Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS

May 20, 2020 Research and Development COVID-19, Diabetics, coronavirus, diabetes

People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …
News
moderna-605x340

Interim data for Moderna’s COVID-19 vaccine shows glimmers of hope

May 19, 2020 Manufacturing and Production, Research and Development COVID-19, Moderna, Vaccine, coronavirus, pharma

Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …
News
shutterstock

New study on COVID-19 immune response shows promise for vaccine development

May 18, 2020 Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

Researchers at the labs of Dr Alessandro Sette and Dr Shane Crotty at California’s La Jolla Institute for Immunology have …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026